Vol 32, No 4S1 (2018) - Article
EFFICACY OF ABL001 - ALONE OR IN COMBINATION - ON CD34+ PROGENITORS ISOLATED FROM CML PATIENTS DISPLAYING HIGH OR LOW BCR-ABL TRANSCRIPTS AT DIAGNOSIS Abstract
Vol 32, No 4S1 (2018) - Article
CHK1 INHIBITION RESTORES INOTUZUMAB OZOGAMICIN CITOTOXICITY IN CD22-POSITIVE CELLS EXPRESSING MUTANT P53 Abstract
Vol 32, No 4S1 (2018) - Article
ATYPICAL BCR-ABL BREAKPOINTS DISPLAY SELECTIVE RESPONSIVENESS TO TYROSINE KINASE INHIBITORS Abstract
Vol 32, No 4S1 (2018) - Article
CLINICAL IMPACT OF EARLY MOLECULAR RESPONSE IN CML PATIENTS TREATED WITH IMATINIB Abstract
